Shanghai Haohai Biological Technology Co. Ltd (5HB) — Strategic Asset Allocation Index

Latest as of June 2023: 24.9%

Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Strategic Asset Allocation Index of 24.9% as of June 2023. Strategic assets (PP&E of €1.52 Billion plus long-term investments of €-) total €1.52 Billion, measured against net assets of €6.09 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

24.9%
Strategic Assets / Net Assets

Strategic Assets

€1.52 Billion
PP&E + LT Investments

PP&E

€1.52 Billion
EUR

Net Assets

€6.09 Billion
EUR

Shanghai Haohai Biological Technology Co. Ltd Strategic Asset Allocation Index (2016–2022)

This chart shows how Shanghai Haohai Biological Technology Co. Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 24.9%, representing strategic assets of €1.52 Billion against net assets of €6.09 Billion EUR. Explore 5HB cash generation efficiency to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Shanghai Haohai Biological Technology Co. Ltd (2016–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shanghai Haohai Biological Technology Co (5HB) total market value.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2022 25.6% €1.51 Billion €1.51 Billion €- €5.90 Billion ▲ +2.3 pp
2021 23.3% €1.41 Billion €1.41 Billion €- €6.06 Billion ▲ +2.7 pp
2020 20.6% €1.18 Billion €1.18 Billion €- €5.73 Billion ▲ +0.9 pp
2019 19.7% €1.11 Billion €1.11 Billion €- €5.65 Billion ▲ +1.3 pp
2018 18.4% €703.85 Million €703.85 Million €- €3.84 Billion ▲ +1.0 pp
2017 17.4% €585.76 Million €585.76 Million €- €3.37 Billion ▲ +1.5 pp
2016 15.9% €474.75 Million €474.75 Million €- €2.99 Billion
pp = percentage points